ARC and cancer: Taken together, we report here that phosphorylation of ARC by CK2 contributes to chemotherapy resistance by inhibiting DOX induced apoptosis, whereas, CK2 inhibitor increase the sensitivity of cancer cells to DOX by inhibiting the phosphorylation of ARC.